Drug interactions in COVID-19 treatment. Systematic review
The COVID-19 pandemic has driven the experimental, off-label treatments with co-administration of supportive therapies for many patients with severe infections and coexisting chronic conditions. This situation has inevitably led to polypharmacy, which is always related to a disproportionately large...
Saved in:
Main Authors: | Arkadiusz Adamiszak (Author), Tomasz Torliński (Author), Edmund Grześkowiak (Author), Alicja Bartkowska-Śniatkowska (Author), Agnieszka Bienert (Author) |
---|---|
Format: | Book |
Published: |
Polish Pharmaceutical Society,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential drug-drug interactions in hospitalized patients with COVID-19.
by: Danuta Szkutnik-Fiedler, et al.
Published: (2023) -
Pharmacokinetic Drug Interaction Study of Sorafenib and Morphine in Rats
by: Agnieszka Karbownik, et al.
Published: (2021) -
Adverse reaction to ceftriaxone in a 28-day-old infant undergoing urgent craniotomy due to epidural hematoma: review of neonatal biliary pseudolithiasis
by: Bartkowska-Śniatkowska A, et al.
Published: (2015) -
Adverse outcomes after percutaneous dilatational tracheostomy versus surgical tracheostomy in intensive care patients: case series and literature review
by: Jarosz K, et al.
Published: (2017) -
Drug interactions of ivermectin with a focus on COVID-19 treatment
by: Padmaja Udaykumar, et al.
Published: (2021)